Sponsor content
176 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESPEROCT turoctocog alfa pegol 1500 IU powder for injection vial with solvent.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESPEROCT turoctocog alfa pegol 1000 IU powder for injection vial with solvent.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESPEROCT turoctocog alfa pegol 2000 IU powder for injection vial with solvent.
-
Australian public assessment report (AusPar)Alhemo (concizumab) is approved to prevent or reduce frequency of bleeding in patients who have haemophilia B with FIX inhibitors.
-
Prescription medicine registrationActive ingredients: Semaglutide.
-
Australian public assessment report (AusPar)Esperoct (turoctocog alfa pegol) has been approved to prevent or reduce the frequency of bleeding episodes in patients with haemophilia A.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 0.5 mg semaglutide 1.0 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1 mg semaglutide 2.0 mg/mL solution for injection pre-filled pen with pre-assembled needle.